Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$1.16B |
| 2 |
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
|
+$973M |
| 3 |
Boeing
BA
|
+$825M |
| 4 |
Booking.com
BKNG
|
+$807M |
| 5 |
Las Vegas Sands
LVS
|
+$507M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
Microsoft
MSFT
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$1.01B |
| 4 |
Netflix
NFLX
|
+$835M |
| 5 |
Meta Platforms (Facebook)
META
|
+$745M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.64% |
| 2 | Financials | 11.65% |
| 3 | Consumer Discretionary | 9.35% |
| 4 | Healthcare | 9.23% |
| 5 | Industrials | 8.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Chubb
CB
$135B
| $817K | ﹤0.01% |
4,199
+135
| +3% | +$28.4K |
|
727
Ironwood Pharmaceuticals
IRWD
$711M
| $804K | ﹤0.01% |
76,418
+1,171
| +2% | +$13.1K |
|
728
First Trust Nasdaq-100 Select Equal Weight ETF
QQEW
$1.82B
| $802K | ﹤0.01% |
7,966
-103
| -1% | -$9.88K |
|
729
Philip Morris
PM
$295B
| $800K | ﹤0.01% |
8,226
-2,130
| -21% | -$212K |
|
730
Vitesse Energy
VTS
$665M
| $786K | ﹤0.01% |
+41,285
| New | +$712K |
|
731
Accenture
ACN
$108B
| $751K | ﹤0.01% |
2,627
+58
| +2% | +$15.8K |
|
732
iShares Core MSCI Emerging Markets ETF
IEMG
$156B
| $748K | ﹤0.01% |
15,324
+8,584
| +127% | +$421K |
|
733
Cogent Biosciences
COGT
$7.24B
| $740K | ﹤0.01% |
68,569
| – | – |
|
734
Zimmer Biomet
ZBH
$18.4B
| $739K | ﹤0.01% |
5,711
-841
| -13% | -$106K |
|
735
Celldex Therapeutics
CLDX
$3.27B
| $739K | ﹤0.01% |
20,538
-8,479
| -29% | -$366K |
|
|
PNT
736
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $721K | ﹤0.01% |
99,189
-19,717
| -17% | -$146K |
|
737
Stoneridge
SRI
$213M
| $713K | ﹤0.01% |
+38,124
| New | +$819K |
|
738
iShares US Aerospace & Defense ETF
ITA
$14.7B
| $712K | ﹤0.01% |
6,190
+458
| +8% | +$52.1K |
|
739
iShares TIPS Bond ETF
TIP
$14.5B
| $684K | ﹤0.01% |
6,199
-1,266
| -17% | -$137K |
|
740
Wells Fargo
WFC
$264B
| $668K | ﹤0.01% |
17,877
-4,072
| -19% | -$177K |
|
|
AFMD
741
DELISTED
Affimed
AFMD
| $667K | ﹤0.01% |
89,522
| – | – |
|
742
Weyerhaeuser
WY
$18.4B
| $667K | ﹤0.01% |
22,127
-120
| -0.5% | -$3.78K |
|
743
WisdomTree
WT
$3.22B
| $654K | ﹤0.01% |
111,632
-1,200
| -1% | -$6.99K |
|
744
Fortinet
FTNT
$117B
| $646K | ﹤0.01% |
9,714
-130
| -1% | -$7.39K |
|
745
Mondelez International
MDLZ
$79.9B
| $645K | ﹤0.01% |
9,254
-799
| -8% | -$52.9K |
|
746
Invesco California AMT-Free Municipal Bond ETF
PWZ
$1.16B
| $644K | ﹤0.01% |
26,000
| – | – |
|
747
Comfort Systems
FIX
$59.6B
| $644K | ﹤0.01% |
4,410
-4,474
| -50% | -$580K |
|
748
Marathon Petroleum
MPC
$83.7B
| $640K | ﹤0.01% |
4,749
-721
| -13% | -$90.2K |
|
749
PNC Financial Services
PNC
$101B
| $639K | ﹤0.01% |
5,026
-478
| -9% | -$72.1K |
|
750
Pacific Biosciences
PACB
$370M
| $636K | ﹤0.01% |
54,882
| – | – |
|
Similar funds
Ken Fisher's Q1 2023 Portfolio in Review
As of Q1 2023, Ken Fisher held 1,208 positions worth $165B, up 11% from $148B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Ken Fisher's Q1 2023 filing shows 183 new, 335 increased, 567 reduced and 73 closed positions. Its largest new stake was State Street SPDR Portfolio Short Term Treasury ETF: 33,536,153 shares worth $980M. The largest sale was Apple, an estimated $1.2B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Consumer Discretionary.
- Ken Fisher's largest Q1 2023 buy was State Street SPDR Portfolio Short Term Treasury ETF: 33,536,153 shares worth $980M.
- Ken Fisher added most to Citigroup in Q1 2023, an estimated $1.16B increase.
- Ken Fisher's biggest Q1 2023 reduction was Apple, cutting an estimated $1.2B.
- Ken Fisher fully exited SVB Financial Group in Q1 2023, selling an estimated $114M.
- Ken Fisher's ten largest holdings make up 26% of its $165B portfolio in Q1 2023.
- Ken Fisher opened 183 new positions and closed 73 in Q1 2023.
- Ken Fisher's portfolio value rose 11% quarter-over-quarter to $165B.
Based on Fisher Asset Management's 13F filing for Q1 2023, filed 1 May 2023.